Tejnaksh Healthcare has scheduled its 19th Annual General Meeting for September 29, 2026. The virtual meeting will address ordinary business items including the adoption of financial statements for FY26.

The company will also seek shareholder approval for special resolutions concerning board composition and related-party transactions. The meeting will be conducted via Video Conferencing or Other Audio-Visual Means in compliance with Ministry of Corporate Affairs circulars.

Board Appointments

Shareholders will consider the reappointment of Mr. Sanjay Bhikajirao Khatal as a Director. He retires by rotation and offers himself for reappointment. Mr. Khatal holds a B.Tech in Agricultural Engineering and brings 39 years of administrative and technical experience.

Additionally, the Board seeks a special resolution to reappoint Mr. Suhas Vasantrao Thorat as an Independent Director for a second term of five consecutive years. His tenure will run from August 13, 2026, to August 12, 2031. The Nomination and Remuneration Committee recommended his reappointment based on his continued valuable guidance and strong performance.

Related Party Transactions

The AGM agenda includes an ordinary resolution to approve material related-party transactions for the period until the 20th AGM in 2027. The Audit Committee has approved these transactions, noting they are at arm’s length and in the ordinary course of business.

The proposed transactions with Tej Vedaant Healthcare represent 22.81% of the annual consolidated turnover. Transactions involving Dr. Ashish Rawandale and the Tejnaksh Healthcare Foundation each represent 9.27% of the turnover.

Voting Details

Remote e-voting will commence on September 26, 2026, at 9:00 am and conclude on September 28, 2026, at 5:00 pm. The cut-off date for determining eligible members is September 22, 2026. National Securities Depository Limited (NSDL) will facilitate the e-voting process.

M/s. NS Dave & Associates has been appointed as the Scrutinizer to ensure a fair and transparent voting process. Results will be declared within 48 hours of the meeting's conclusion.

Tejnaksh Healthcare Limited reported a 47.4% decline in consolidated net profit to ₹118.11 lakh for the financial year ended March 31, 2026, as revenue from operations fell 16.3% to ₹1,078.69 lakh. The company's total income for the year stood at ₹1,117.99 lakh, compared to ₹1,330.14 lakh in the previous year. The Board of Directors approved the audited financial results for the standalone and consolidated entities for the quarter and year ended March 31, 2026.

The statutory auditors, M/s Maheshwari and Co, issued an unmodified opinion on the annual financial results. The consolidated financial results include the performance of the subsidiary, Tejvedaant Healthcare Private Limited. For the quarter ended March 31, 2026, the company reported a profit of ₹34.86 lakh, a decrease from ₹42.33 lakh in the corresponding quarter of the previous year.

Financial Performance

The company's expenses for the year totaled ₹953.37 lakh, a reduction from ₹1,011.00 lakh in the prior year. Profit before tax for the year stood at ₹164.62 lakh, significantly lower than the ₹319.14 lakh reported in FY25. The basic and diluted earnings per share (EPS) for the year declined to ₹0.61 from ₹1.15 in the previous year.

Consolidated Financial Results (Year Ended March 31, 2026)

Board Decisions

The Board discussed the proposed offer of shares via Rights Issue and decided not to proceed further with the issue, citing the postponement of the company's expansion plans. Additionally, the Board re-appointed M/s Kapil Tulsani & Associates as the Internal Auditor for the period commencing April 1, 2026, and ending March 31, 2027.

Dr. Ashish V. Rawandale, Managing Director, was authorized to sign and submit requisite forms with the Registrar of Companies for the financial years 2026-2027. The company noted that the New Labour Codes, effective from November 21, 2025, led to a remeasurement of gratuity liability, resulting in a reversal recognized as Other Income in the current reporting period.